National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

dornase alfa inhalation solution
A highly purified solution of recombinant human deoxyribonuclease I (rhDNAse) with selective DNA cleaving activity. Administrated through inhalation of the nebulized solution, dornase alpha catalyzes DNA degradation in viscous airway secretions, which may render airway secretions less viscous, thus promoting the clearing of airway mucous plugging and improvement in pulmonary function. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:recombinant human deoxyribonuclease I inhalation solution
US brand name:Pulmozyme
Abbreviation:rhDNase inhalation solution



Previous:Dolophine, Domestrol, Domolene-HC, donepezil hydrochloride, Dopar
Next:Dox-SL, doxercalciferol, doxifluridine, DOXIL, doxorubicin hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov